Press Release Sep 05 2025
Filed with NSE · · 2 pages · English
Summary by 6ix AI
Zydus Lifesciences Limited has issued a press release regarding the closure of a USFDA inspection at its injectable manufacturing plant in Jarod. The inspection took place from late August to early September and resulted in four observations, none related to data integrity. The company plans to work closely with the USFDA to address these observations promptly.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Sep 04 2025
- Zydus and Synthon entered into exclusive licensing and supply agreement for Ozanimod Capsules (generic version of ZEPOSIA®) for the U.S. market
- Press Release Sep 02 2025
- Press Release Aug 29 2025
- Zydus Therapeutics Reports Positive Topline Results from EPICS-III Phase 2(b)/3 Trial of Saroglitazar Magnesium in Patients with Primary Biliary Cholangitis
Later from Zydus Lifesciences
- Press Release Sep 15 2025
- Zydus Lifesciences Limited Press Release Sep 21 2025
- Press Release Sep 23 2025
- Press Release Oct 01 2025
- Press Release Oct 06 2025
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences